NORTHERN TRUST CORP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 169 filers reported holding CARDLYTICS INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$4,661,201
+174.3%
282,497
+5.1%
0.00%
Q2 2023$1,699,499
+91.5%
268,908
+2.9%
0.00%
Q1 2023$887,503
-45.6%
261,415
-7.5%
0.00%
Q4 2022$1,632,740
-40.8%
282,481
-3.7%
0.00%
-100.0%
Q3 2022$2,758,000
-59.6%
293,380
-4.1%
0.00%0.0%
Q2 2022$6,826,000
-60.0%
305,913
-1.3%
0.00%
-66.7%
Q1 2022$17,047,000
-20.1%
310,038
-4.0%
0.00%0.0%
Q4 2021$21,337,000
-21.3%
322,855
-0.1%
0.00%
-40.0%
Q3 2021$27,129,000
-39.1%
323,198
-7.9%
0.01%
-37.5%
Q2 2021$44,521,000
+18.2%
350,752
+2.1%
0.01%
+14.3%
Q1 2021$37,675,000
-18.2%
343,441
+6.4%
0.01%
-22.2%
Q4 2020$46,082,000
+96.7%
322,775
-2.8%
0.01%
+80.0%
Q3 2020$23,429,000
-0.3%
331,984
-1.2%
0.01%
-16.7%
Q2 2020$23,508,000
+245.1%
335,933
+72.4%
0.01%
+200.0%
Q1 2020$6,811,000
-43.5%
194,827
+1.6%
0.00%
-33.3%
Q4 2019$12,050,000
+114.0%
191,688
+14.1%
0.00%
+200.0%
Q3 2019$5,630,000
+121.9%
167,978
+72.0%
0.00%0.0%
Q2 2019$2,537,000
+103.1%
97,635
+29.3%
0.00%
Q1 2019$1,249,000
+54.2%
75,527
+1.0%
0.00%
Q4 2018$810,000
-60.9%
74,785
-9.6%
0.00%
-100.0%
Q3 2018$2,070,000
+37.5%
82,682
+19.4%
0.00%
Q2 2018$1,506,000
+79.3%
69,256
+20.7%
0.00%
Q1 2018$840,00057,3630.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders